Dr. Timothy Michael Strouse II, MD

Dr. Strouse practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Strouse's NPI, 1306032503, was assigned on September 20, 2007. Dr. Strouse graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2005. Dr. Strouse holds California license A98750.

Dr. Strouse's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Strouse's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. Dr. Strouse is also affiliated with Sharp Memorial Hospital. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Dr. Strouse to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Strouse practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Strouse's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Strouse is board certified in internal medicine by the American Board of Internal Medicine. Dr. Strouse is licensed in California.

Dmand AI lists acute mini-stroke (TIA), acute sinusitis, aneurysm, anxiety, arthritis, atrial fibrillation and flutter, bursitis and chronic diabetes among the conditions Dr. Strouse treats.

CMS data shows 496 Medicare services from Dr. Strouse across 5 procedure codes in 2024, for 210 Medicare patients. Medicare paid $38,380 for them. Every service was in an office.

CMS counts 210 Medicare patients who saw Dr. Strouse in 2024. The largest group is 65 to 74, with 106 patients. 74% of them have high blood pressure, and 73% have high cholesterol. Their average risk score is 0.80, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Strouse's median patient age at 65, with 31% women.

In 2024, Dr. Strouse wrote 6,543 Medicare Part D claims for 548 patients. 89% of them were for generic drugs. CMS names the drug for 5,982 of them, across 102 drugs with 11 or more claims each, at $610,317 in total drug cost. In 2023, CMS named 5,627 claims across 99 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Strouse for performance year 2024, reported as part of a group. Dr. Strouse accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Strouse as offering telehealth.

CMS Open Payments shows 5 general payments to Dr. Strouse from 3 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $125.

Dr. Strouse graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2005.

Dr. Strouse is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.